These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26812297)

  • 1. Sunitinib treatment for multifocal renal cell carcinoma (RCC) and pancreatic neuroendocrine tumor (NET) in patient with Von Hippel-Lindau disease. Case Report.
    Babinska A; Studniarek M; Świątkowska-Stodulska R; Sworczak K
    Neuro Endocrinol Lett; 2015 Dec; 36(6):517-20. PubMed ID: 26812297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response.
    Roma A; Maruzzo M; Basso U; Brunello A; Zamarchi R; Bezzon E; Pomerri F; Zovato S; Opocher G; Zagonel V
    Fam Cancer; 2015 Jun; 14(2):309-16. PubMed ID: 25391617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sunitinib treatment for metastatic renal cell carcinoma in patients with von hippel-lindau disease.
    Kim HC; Lee JS; Kim SH; So HS; Woo CY; Lee JL
    Cancer Res Treat; 2013 Dec; 45(4):349-53. PubMed ID: 24454008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group.
    Oudard S; Elaidi R; Brizard M; Le Rest C; Caillet V; Deveaux S; Benoit G; Corréas JM; Benoudiba F; David P; Gaudric A; Hammel P; Joly D; Timsit MO; Méjean A; Richard S
    Oncotarget; 2016 Dec; 7(51):85306-85317. PubMed ID: 27852035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau disease.
    Yuan G; Liu Q; Tong D; Liu G; Yi Y; Zhang J; Zhang Y; Wang LA; Wang L; Chen R; Guan Y; Yi X; Lan W; Jiang J
    Cancer Biol Ther; 2018; 19(9):766-772. PubMed ID: 29947576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Hippel-Lindau and myotonic dystrophy of Steinert along with pancreatic neuroendocrine tumor and renal clear cell carcinomal neoplasm: Case report and review of the literature.
    Addeo A; Bini R; Viora T; Bonaccorsi L; Leli R
    Int J Surg Case Rep; 2013; 4(8):648-50. PubMed ID: 23774333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
    Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
    Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced renal cell carcinoma associated with von Hippel-Lindau disease: A case report and review of the literature.
    Zhang L; Xu B; Wang Y; Liu C; Lu K; Huang Y; Liu N; Zhang X; Chen S; Chen M
    Oncol Lett; 2015 Aug; 10(2):1087-1090. PubMed ID: 26622630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
    Jimenez C; Cabanillas ME; Santarpia L; Jonasch E; Kyle KL; Lano EA; Matin SF; Nunez RF; Perrier ND; Phan A; Rich TA; Shah B; Williams MD; Waguespack SG
    J Clin Endocrinol Metab; 2009 Feb; 94(2):386-91. PubMed ID: 19017755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 Patients.
    Ma K; Hong B; Zhou J; Gong Y; Wang J; Liu S; Peng X; Zhou B; Zhang J; Xie H; Zhang K; Li L; Cai D; Wang Z; Cai L; Gong K
    Front Oncol; 2019; 9():1122. PubMed ID: 31737565
    [No Abstract]   [Full Text] [Related]  

  • 11. Von Hippel-Lindau: how a rare disease illuminates cancer biology.
    Richard S; Gardie B; Couvé S; Gad S
    Semin Cancer Biol; 2013 Feb; 23(1):26-37. PubMed ID: 22659535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sunitinib treatment of metastatic renal cell carcinoma in von Hippel-Lindau disease.
    Tsimafeyeu I
    J Cancer Res Ther; 2015; 11(4):920-2. PubMed ID: 26881543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial and genetic study in a large Chinese kindred with von Hippel-Lindau disease and gene mutation analysis].
    Zhang J; Huang YR; Wang JD; Fan XD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):5-9. PubMed ID: 14767899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
    Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
    J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
    Huang YR; Zhang J; Wang JD; Fan XD
    Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
    Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
    Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease.
    Granata A; Sessa A; Righetti M; Cordaro S; Leone G; Figura M; Fatuzzo P; Rapisarda F; Di Maria E; Ciotti P; Mandich P; Nardo A; Ferrone M; Gallone S; Liuzzo G
    J Nephrol; 2004; 17(2):306-10. PubMed ID: 15293534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic renal cell carcinoma versus pancreatic neuroendocrine tumor in von Hippel-Lindau disease: treatment with interleukin-2.
    Williams C; Walther M
    ScientificWorldJournal; 2005 Jan; 5():9-10. PubMed ID: 15674444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
    Lott ST; Chandler DS; Curley SA; Foster CJ; El-Naggar A; Frazier M; Strong LC; Lovell M; Killary AM
    Cancer Res; 2002 Apr; 62(7):1952-5. PubMed ID: 11929809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total pancreatectomy for multiple neuroendocrine tumors of the pancreas in a patient with von Hippel-Lindau disease.
    Maeda H; Nishimori I; Okabayashi T; Kohsaki T; Shuin T; Kobayashi M; Onishi S; Hanazaki K
    Clin J Gastroenterol; 2009 Jun; 2(3):222-225. PubMed ID: 26192301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.